New Chancery Challenge Launched To Board-Investor Pacts

A biopharmaceutical company stockholder has teed up a new Delaware Chancery Court suit challenging board-investor voting agreements, with the complaint acknowledging wide debate over the pacts and a fast-moving push to...

Already a subscriber? Click here to view full article